Cargando…
Emerging role of insulin with incretin therapies for management of type 2 diabetes
Type 2 diabetes mellitus (T2DM) is a progressive disease warranting intensification of treatment, as beta-cell function declines over time. Current treatment algorithms recommend metformin as the first-line agent, while advocating the addition of either basal-bolus or premixed insulin as the final l...
Autores principales: | Ahluwalia, Rupa, Vora, Jiten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare Communications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173595/ https://www.ncbi.nlm.nih.gov/pubmed/22127824 http://dx.doi.org/10.1007/s13300-011-0005-0 |
Ejemplares similares
-
Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
por: Vora, Jiten
Publicado: (2013) -
Combining incretin-based therapies with insulin: realizing the potential in type 2 diabetes. Diabetes Care 2013;36(Suppl. 2):S226–S232
por: Vora, J
Publicado: (2013) -
Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023) -
The evolving place of incretin-based therapies in type 2 diabetes
por: Gallwitz, Baptist
Publicado: (2010) -
Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus
por: Cobble, Michael
Publicado: (2012)